Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by-nc (c) Ferrata Storti Foundation, 2023
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/209662

BCL3-rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

The t(14;19)(q32;q13) often juxtaposes BCL3 with immunoglobulin heavy chain (IGH) resulting in overexpression of the gene. In contrast to other oncogenic translocations, BCL3 rearrangement (BCL3-R) has been associated with a broad spectrum of lymphoid neoplasms. Here we report an integrative whole-genome sequence, transcriptomic, and DNA methylation analysis of 13 lymphoid neoplasms with BCL3-R. The resolution of the breakpoints at single base-pair revealed that they occur in two clusters at 5' (n=9) and 3' (n=4) regions of BCL3 associated with two different biological and clinical entities. Both breakpoints were mediated by aberrant class switch recombination of the IGH locus. However, the 5' breakpoints (upstream) juxtaposed BCL3 next to an IGH enhancer leading to overexpression of the gene whereas the 3' breakpoints (downstream) positioned BCL3 outside the influence of the IGH and were not associated with its expression. Upstream BCL3-R tumors had unmutated IGHV, trisomy 12, and mutated genes frequently seen in chronic lymphocytic leukemia (CLL) but had an atypical CLL morphology, immunophenotype, DNA methylome, and expression profile that differ from conventional CLL. In contrast, downstream BCL3-R neoplasms were atypical splenic or nodal marginal zone lymphomas (MZL) with mutated IGHV, complex karyotypes and mutated genes typical of MZL. Two of the latter four tumors transformed to a large B-cell lymphoma. We designed a novel fluorescence in situ hybridization assay that recognizes the two different breakpoints and validated these findings in 17 independent tumors. Overall, upstream or downstream breakpoints of BCL3-R are mainly associated with two subtypes of lymphoid neoplasms with different (epi)genomic, expression, and clinicopathological features resembling atypical CLL and MZL, respectively.

Citació

Citació

CARBÓ-MEIX, Anna, GUIJARRO TOMÀS, Francisca, WANG, Luojuon, GRAU, Marta, ROYO, Romina, FRIGOLA, Gerard, PLAYÀ ALBINYANA, Heribert, BÜHLER, Marco m., CLOT RAZQUIN, Guillem, DURAN FERRER, Martí, LU, Junyan, GRANADA, Isabel, BAPTISTA, Maria joao, NAVARRO, José-tomás, ESPINET SOLÀ, Blanca, PUIGGRÒS METJE, Anna maria, TAPIA, Gustavo, BANDIERA, Laura, DE CANAL, Gabriella, BONOLDI, Emanuela, CLIMENT, Fina, RIBERA CORTADA, Inmaculada, FERNÁNDEZ-CABALLERO, Mariana, DE LA BANDA, Esmeralda, DO NASCIMENTO, Janilson, PINEDA, Alberto, VELA, Dolors, ROZMAN, María, AYMERICH GREGORIO, Marta, SYRYKH, Charlotte, BROUSSET, Pierre, PERERA, Miguel, YÁÑEZ, Lucrecia, ORTIN, Jesús xavier, TUSET, Esperanza, ZENZ, Thorsten, COOK, James r., SWERDLOW, Steven h., MARTÍN-SUBERO, José ignacio, COLOMER PUJOL, Dolors, MATUTES, Estella, BEÀ BOBET, Sílvia m., COSTA, Dolors, NADEU PRAT, Ferran, CAMPO GÜERRI, Elias. BCL3-rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases. _Haematologica_. 2023. Vol. 109, núm. 2. [consulta: 24 de gener de 2026]. ISSN: 0390-6078. [Disponible a: https://hdl.handle.net/2445/209662]

Exportar metadades

JSON - METS

Compartir registre